Nicorandil-induced peripheral vasodilatation during cardiopulmonary bypass

被引:4
作者
Falase, BA [1 ]
Bajaj, BS
Wall, TJ
Argano, V
Youhana, AY
机构
[1] Morriston Hosp, Reg Cardiac Ctr, Dept Cardiothorac Surg, Swansea SA6 6NL, W Glam, Wales
[2] Morriston Hosp, Reg Cardiac Ctr, Dept Cardiol, Swansea SA6 6NL, W Glam, Wales
[3] Morriston Hosp, Reg Cardiac Ctr, Dept Anaesthet, Swansea SA6 6NL, W Glam, Wales
关键词
D O I
10.1016/S0003-4975(99)00132-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nicorandil is an antianginal agent with actions at epicardial coronary arteries and arterioles, systemic arterioles, and veins. We report our experience with 7 patients taking oral Nicorandil who had severe vasodilation and hypotension requiring significant vasoconstrictor support after cardiopulmonary bypass. Although the mechanism for this phenomenon remains unknown Nicorandil might be interacting with other factors present during cardiopulmonary bypass, as it has relatively mild hemodynamic effects outside this situation. (Ann Thorac Surg 1999;67:1158-9) (C) 1999 by The Society of Thoracic Surgeons.
引用
收藏
页码:1158 / 1159
页数:2
相关论文
共 3 条
[1]   HEMODYNAMIC AND CLINICAL EFFECTS OF AN INTRAVENOUS POTASSIUM CHANNEL OPENER - A REVIEW [J].
KATO, K .
EUROPEAN HEART JOURNAL, 1993, 14 :40-47
[2]   Sinus arrest and severe peripheral vasodilation following cardiopulmonary bypass in a patient taking nicorandil [J].
Montgomery, H ;
Sumeray, M ;
Carr, C ;
Singer, M .
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (01) :81-81
[3]   NICORANDIL SAFETY IN THE LONG-TERM TREATMENT OF CORONARY HEART-DISEASE [J].
WITCHITZ, S ;
DARMON, JY .
CARDIOVASCULAR DRUGS AND THERAPY, 1995, 9 :237-243